Length 187 pages

Date published August 2009

 Print copies are available upon request. Call 781-972-5444. 

 

Corporate subscriptions:
Contact 
David Cunningham,
Global Report Sales
781-972-5472

Questions and to order by phone:
Contact Rose LaRaia
Customer Service
781-972-5444



Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment Tables and Figures

 

Author: Mark C. Via

FIGURES
Figure 1.1. Structure of an Antibody
Figure 2.1. Monoclonal Antibody Production
Figure 2.2. Antibody Engineering
Figure 2.3. Engineered Forms of Antibodies

TABLES
Table 3.1. FDA-Approved Therapeutic Monoclonal Antibodies
Table 3.2. Unconjugated Monoclonal Antibodies in Clinical Trials for Cancer
Table 3.3. Conjugated Monoclonal Antibodies in Clinical Trials for Cancer
Table 3.4. Monoclonal Antibodies in Clinical Trials for Immunological Diseases
Table 3.5. Monoclonal Antibodies in Clinical Trials for Infectious Diseases
Table 3.6. Monoclonal Antibodies in Clinical Trials for Cardiovascular Diseases
Table 3.7. Other Therapeutic Monoclonal Antibodies in Clinical Development
Table 4.1. Worldwide Sales of Therapeutic Monoclonal Antibodies, 2007 and 2008
Table 4.2. Estimated New Cancer Cases in United States, Total and Selected Types, 2009